Full Text
PCN21 DRUG UTILIZATION, COST CONSIDERATIONS AND TRANSFUSION PATTERNS FOR ERYTHROPOIETIC STIMULATING AGENTS IN A MANAGED CARE CANCER POPULATION

Abstract

Authors

A Gosselin M Duh P Lefebvre S Mody B Bookhart RS Mckenzie

Back to Volume 10, Issue 3
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×